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Protein fatty acylation regulates diverse aspects of
cellular function and organization and plays a key
role in host immune responses to infection. Acylation
also modulates the function and localization of virus-
encoded proteins. Here, we employ chemical pro-
teomics tools, bio-orthogonal probes, and capture
reagents to study myristoylation and palmitoylation
during infection with herpes simplex virus (HSV).
Using in-gel fluorescence imaging and quantitative
mass spectrometry, we demonstrate a generalized
reduction in myristoylation of host proteins, whereas
palmitoylation of host proteins, including regulators
of interferon and tetraspanin family proteins, was
selectively repressed. Furthermore, we found that a
significant fraction of the viral proteome undergoes
palmitoylation; we identified a number of virus mem-
brane glycoproteins, structural proteins, and ki-
nases. Taken together, our results provide broad
oversight of protein acylation during HSV infection,
a roadmap for similar analysis in other systems,
and a resourcewith which to pursue specific analysis
of systems and functions.
INTRODUCTION
Covalent modification of proteins by saturated fatty acids rep-
resents a critical regulatory mechanism in processes including
membrane and microdomain targeting, vesicular transport,
signaling, cell structure, metabolic pathways, neurotransmis-
sion, infection, and immunity (Aicart-Ramos et al., 2011; Bijl-
makers, 2009; Iwanaga et al., 2009; Resh, 2012). Examples in
infection and immunity include LCK function, wherein mutants
with amino acid substitutions that block myristoylation or palmi-
toylation are unable to reconstitute T-cell activation (Kabouridis
et al., 1997; Yasuda et al., 2000; Yurchak and Sefton, 1995).
The role of LCK acylation is not restricted to a membrane-
binding function, since a variant that localizes to the plasma
membrane through a transmembrane domain instead of pal-1008 Chemistry & Biology 22, 1008–1017, August 20, 2015 ª2015 Thmitoylation is unable to efficiently reconstitute T-cell receptor
signaling (Kabouridis et al., 1997). Interferon-induced transmem-
brane protein 3 (IFITM3) is involved in innate responses to flu,
dengue fever, and West Nile virus (Brass et al., 2009), and it
has recently been shown that S-palmitoylation of IFITM3 con-
trols clustering in membrane compartments and its antiviral
activity (Yount et al., 2010). Analysis of the family suggests that
S-palmitoylation may be an ancient post-translational modifica-
tion that is crucial for host resistance to viral infections. In addi-
tion to modulating compartmentalization, stability, and function
of host proteins, lipid modification of virus-encoded proteins
also plays a key role in virus replication and immune responses
to infection. For example, in HIV, gp41 is palmitoylated at internal
sites while Gag is subject to N-terminal myristoylation promoting
incorporation of Gag into lipid rafts, multimerization, and particle
budding (Resh, 2004). In hepatitis B virus myristoylation of sur-
face protein sAg is required for infectivity (Gripon et al., 1995;
Macrae et al., 1991). In this case a C-terminal transmembrane
region anchors sAg protein to the virus envelope membrane
and themyristoylated N-terminus on the virus exterior is involved
in cell entry (Bruss et al., 1996). In the herpesviruses UL11, a
conserved and essential structural protein, is subject to both
myristoylation and palmitoylation, modifications that are essen-
tial for normal membrane association (Loomis et al., 2001;
MacLean et al., 1989). Both human cytomegalovirus and Ep-
stein-Barr virus encode homologs of UL11 (UL99 and BBLF1,
respectively), which have also been shown to be lipidated; the
precise nature of the lipidation in relation to virus assembly re-
mains to be determined, but these proteins are all required for
virus replication (Chiu et al., 2012; Sanchez et al., 2000). It has
been also reported that another herpes simplex virus (HSV)
tegument protein, UL51, undergoes palmitoylation, although
the importance of this modification has not been studied in detail
(Nozawa et al., 2003). From these and other examples, it is clear
that covalent modification of host- and virus-encoded proteins
plays important roles in many aspects of virus-host interaction
including entry, assembly, and immune responses.
Studies on the role of protein acylation during infection are
frequently reported on an individual case-by-case basis rather
than from systematic unbiased analysis using high-throughput
techniques such as mass spectrometry (MS)-based proteomic
approaches.Whileadvances inMSenableglobalprofilingofmany
post-translational modifications, identification and quantificatione Authors
Figure 1. Enrichment Strategy
Chemoproteomic Workflow (A), Structures of
Lipid Probes (B), and Multi-functional Capture
Reagent AzTB (C). Inside the cell and the test
tube, colored shapes represent proteins, the triple
bar represents alkyne; on the capture reagent
(AzTB), red N3 represents azide, the pink star
represents TAMRA fluorophore, and the blue
double pentagon represents biotin.ofprotein fattyacylationbystandardMSremainsverychallenging.
Acylation negatively affects solubility, chromatographic proper-
ties, and ionization of lipid-anchored tryptic peptides, rendering
MS detection difficult. Furthermore, lipidated proteins often exist
in low abundance in cells; therefore, lipid-specific enrichment is
required to reduce sample complexity and improve discovery.
An enrichment strategy that utilizes introduction of a chemical
reporter via metabolic taggingwith lipid probes in cell culture (Fig-
ure 1A) has becomeamethod of choice to study proteinmyristoy-
lation and palmitoylation, as well as other classes of lipidation
(Berry et al., 2010; Broncel et al., 2015; Ciepla et al., 2014; Konit-
siotis et al., 2015; Martin and Cravatt, 2009; Tate et al., 2015; Wil-
son et al., 2011; Wright et al., 2015). u-Alkynyl fatty acid analogs
(Figure 1B) can be used formetabolic tagging of acylated proteins
andsubsequently elaboratedbyahighlyselective ligation reaction
(copper-catalyzed azide alkyne cycloaddition [CuAAC]) (Rostovt-
sevet al., 2002;Tornoeetal., 2002) toamulti-functional azidocap-
ture reagent (AzTB, Figure 1C) enabling visualization (via the
TAMRA component), enrichment (via the biotin component), and
subsequent stepsof on-bead tryptic digestion,MSmeasurement,
software-aided peptide sequencing and identification, as well as
quantification of fatty acylated proteins (Storck et al., 2013). In
the work reported here, we applied chemical technologies with
systems proteomic approaches to make comprehensive ad-
vances in the investigation of fatty acylation of virus and host
proteins in a complex but tractable systemwithmajor clinical rele-
vance in human disease, the human herpesviruses.
RESULTS
Selective Modulation of Protein Acylation During HSV
Infection
In a series of preliminary experiments, uninfected cells were incu-
bated with a range of concentrations (1–50 mM) of the probes
for protein palmitoylation (YnPal) and myristoylation (YnMyr).
The results indicated a concentration of 25 mM was optimal
for both probes, with no apparent toxicity observed comparedChemistry & Biology 22, 1008–1017,with vehicle (DMSO) over the 24-hr expo-
sure time as measured by viable cell
counting (Figure S1). Cells were then
mock infected or infected with HSV-1[17]
at anMOI of 5, i.e. an average of five infec-
tious particles per cell, ensuring quantita-
tive infection of all the cells for comparison
with uninfected samples, and then pulse-
labeled with YnPal and YnMyr lipid
probes. Metabolically tagged, acylated
proteins were subsequently ligated toAzTB, extracted, and visualized firstly by in-gel fluorescence (Fig-
ure 2). Distinct species were observed for HSV-infected versus
mock-infected cells. For palmitoylation, candidate host species
(Figure 2, open arrowheads) progressively reduced in abundance
while a series of new species were observed, increasing with time
after infection (Figure 2, solid arrows, lanes 1–4). A generally
similar trend was observed for the myristoylation probe (Figure 2,
solid arrows, lanes 5–8), with certain speciesmigrating similarly to
those observed with the palmitoylation probe.
These resultsdemonstrateprogressivealteration in theacylated
protein profiles. Nevertheless, qualitative analysis by SDS-PAGE
and in-gel fluorescence, while useful as a preliminary survey, is
clearly limited for the ambition of a more broad-based analysis,
including targetprotein identification.We therefore next employed
MS combined with isotopic tagging methodology, stable isotope
labeling by amino acid in cell culture (SILAC) (Ong et al., 2002),
to identify and quantitate HSV-induced changes to lipid fatty acyl-
ation. In this approach (Figure 3A) cells to be infected are labeled
with medium containing 13C6
15N4-arginine and
13C6
15N2-lysine
(heavy), whereas cells to be mock infected are incubated in me-
diumwith arginine and lysine at natural isotopic distribution (light).
Cells were infected or mock infected, incubated in heavy or light
medium, respectively, and pulsed with the lipid probes. Mock-in-
fected or infected cells were then harvested (19 hr post infection
[hpi]) and the proteins extracted. After determining the total con-
centrations, proteins were mixed in a 1:1 ratio, subject to CuAAC
ligation to AzTB, and affinity enriched on NeutrAvidin beads. The
labeled, purified proteins were then subject to tryptic digestion
and MS measurements (see Experimental Procedures). As part
of this work flow, the isotope labeling was also reversed, whereby
HSV-infected cells were incubated in light medium and mock-in-
fected cells in heavy medium, thus minimizing experimental bias
and aiding identification of incidental contaminants. For each
probe, biological quadruplicate experiments were performed,
measurement outcomespooled, andproteins identified on a strict
filtering basis requiring presence in replicate samples for inclusion
in subsequent evaluation. The data were then further subjected toAugust 20, 2015 ª2015 The Authors 1009
Figure 2. In-Gel Fluorescent Analysis of Protein Fatty Acylation
During HSV Infection in RPE-1 Cells
Cells were pulsedwith YnPal or YnMyr (25 mM) for 6 hr and harvested at various
times as shown. Proteins were isolated, processed for coupling to capture
reagent AzTB, and analyzed for palmitoylation (A) or myristoylation (B). Arrows
point to bands of increased fluorescence intensities (proteins with increased
acylation levels) and arrowheads point to bands with decreased fluorescence
intensities (proteins with decreased acylation levels).statistical analysis to identify proteins with significantly different
lipidation status in infected and uninfected cells.
This analysis returned information on 1,292 grouped protein
candidates forpalmitoylationand208 formyristoylation, revealing
overall down-regulation of both protein modifications in HSV-in-
fected cells compared with uninfected cells (Figures 3B and 3C,
respectively). No host proteins were identified with increases in
palmitoylation or myristoylation levels, attributing the increase in
acylated species during infection (Figure 2) to HSV-encoded
proteins.
Each dot in the Figures 3B and 3C represents an individual pro-
tein (or a small group of closely related proteins, e.g. isoforms)
(Cox et al., 2011), and the complete datasets are summarized
in Tables S1 and S2. Of 1,292 host protein groups enriched
upon tagging with YnPal (Table S1), significant decreases in pal-
mitoylation in HSV-infected cells were observed for 116 proteins,
out of which 107 (92%) were annotated as intrinsic to a mem-
brane. Of the 116 proteins (Table S1) with reduced levels of
palmitoylation (>2-fold decrease) a number of proteins were
quantified, including CXADR (Coxsackie virus and adenovirus
receptor), ANO6, a protein involved in regulating membrane
phospholipid asymmetry, andmembers of the tetraspanin family,
e.g. CD63, CD81, and CD82, several of which are known to be
palmitoylated and to form microdomains in the plasma mem-
brane.Of the208proteins identified formyristoylation (Figure3C),
107 exhibited reduced levels of myristoylation (>2-fold decrease,
Table S2). Of these, 80 have been robustly validated asmyristoy-
lated proteins (Broncel et al., 2015; Thinon et al., 2014).1010 Chemistry & Biology 22, 1008–1017, August 20, 2015 ª2015 ThSelective Suppression of Host Protein Palmitoylation
During HSV Infection
While these data catalog reduction in myristoylation and palmi-
toylation of host proteins during HSV infection, further analyses
were nevertheless required to examine selectivity in these ef-
fects. This stems from the consideration that whilemyristoylation
is generally a co-translational irreversible process linked to
nascent synthesis of potential substrates, palmitoylation is a
post-translational modification that is often dynamic and there-
fore affected by the total abundance of substrate proteins. In
addition, palmitoylation of certain proteins occurs shortly after
their biosynthesis and undergoes minimal turnover (Martin
et al., 2012). As a result, certain aspects of acylation could be
sensitive to host protein synthesis shutoff events induced by vi-
ruses such as HSV (Everly et al., 2002; Read and Frenkel, 1983;
Suzutani et al., 2000).
We therefore next performed a series of additional analyses
to take account of first, the total levels of protein substrates;
second, the levels of nascent protein synthesis in infected versus
uninfected cells; and third, the effect of protein synthesis inhi-
bition per se. For the first two aims, we performed a set of
SILAC-MS-based analyses in which total as well as newly syn-
thesized protein abundances were quantified in HSV-infected
and mock-infected cells. In the first analysis, mock-infected
(light) and HSV-infected (heavy) samples from the workflow in
Figure 3A were mixed in a 1:1 ratio, and the total sample prior
to enrichment subject to tryptic digestion, MS, and quantitative
analysis of the ratios of proteins in the total proteome was
performed. The experiment revealed no significant alterations
to abundances of the vast majority (99.6%) of 1,428 host protein
groups that were rigorously quantified (Table S3). We noted that
total abundances of a small number of proteins were significantly
decreased in HSV-infected samples, including LRPPRC, PLD3,
PRKDC, SERPINE1, and TGOLN2, none of which has been an-
notated as acylated. These data suggest that the observed
down-regulation of acylation does not simply reflect differential
total protein abundances.
In the next experiments, we examined alterations of nascent
protein abundance in infected versus uninfected cells, and their
relationship to protein acylation using a SILAC/pulse-chase
protocol (Figure 4A). Cells in light medium were mock infected
or infected and transferred to heavy medium, and incubation
continued to compare heavy isotope incorporation into nascent
proteins during the labeling period in uninfected versus HSV-in-
fected cells. Equal amounts of the mock-infected and infected
lysates were spiked with a fixed amount of protein from cells
labeled by SILAC with an intermediate (medium) isotopic label,
enabling normalization between samples through a standard
‘‘spike-in SILAC’’ approach (Geiger et al., 2011). Since we antic-
ipated that these data might return only a small set particularly
for the myristoylated proteins, we included a pulse with YnMyr
prior to isotope labeling to enable enrichment and detection of
this set, alongside the nascent analysis for all proteins. The
spiked mixtures of total proteins were then subjected to tryptic
digestion and MS analysis. In parallel, the YnMyr-tagged protein
populations from the same lysate mixtures were ligated to
AzTB, affinity-captured, and analyzed by on-bead digest and
MS. The ratio of heavy/medium signal for mock- and HSV-in-
fected samples yields information on changes in the abundancee Authors
Figure 3. Quantitative Proteomics Analysis of Host Protein Fatty Acylation During HSV Infection in RPE-1 Cells
(A) SILAC-based quantitative proteomics workflow.
(B) Virus-induced changes to protein palmitoylation (n = 4) plotted against statistical significance of the ratio measured.
(C) Virus-induced changes to proteinmyristoylation (n = 4) plotted against statistical significance. Black, proteins withmyristoylation requirement (N-terminal Gly);
red, validated NMT substrates (Broncel et al., 2015; Thinon et al., 2014).
In (B) and (C) each data point represents a protein or a protein group (Cox et al., 2011).of individual proteins (all proteins) synthesized during the time
frame of the experiment, and the affinity-captured sample gives
the same information specifically for the myristoylated popula-
tion. The results for nascent protein abundance in HSV- versus
mock-infected cells, plotted against significance of the differ-
ence for all proteins, are shown in Figure 4B. Overall the results
for 510 proteins quantitated (Table S4) revealed a significant
down-regulation of protein synthesis in HSV-infected cells, in
keeping with previous data (Suzutani et al., 2000), consistent
with the known progression of HSV infection. To selectively
examine nascent abundances for myristoylated proteins, the
average fold (Log2) decrease among potential substrates (with
myristoylation recognition motifs) was 1.86 ± 0.53 (33 protein
groups). The average fold decrease among substrates purified
by affinity enrichment for YnMyr and satisfying the criteria of
possession of an N-terminal glycine and previous identification
as myristoylated proteins (Broncel et al., 2015; Thinon et al.,
2014) was 3.17 ± 0.23 (eight protein groups) (Table S4). There-
fore, comparing the decrease in levels of nascent protein
abundances from this analysis with the decrease in levels of
myristoylation among validated substrates (Table S2), the
effects were2.33 ± 0.69 and3.17 ± 0.23, respectively. These
data suggest, therefore, that the apparent decrease in host pro-
tein myristoylation largely results from suppression of host pro-
tein synthesis in infected cells. In support of this, we note that
total abundances of NMT1 and NMT2 in HSV- and mock-in-
fected cells were very similar (Table S3), with average ratios of
1.13 ± 0.18 (four samples) and 1.12 ± 0.25 (seven samples),
respectively.
In contrast, with regard to HSV effects on palmitoylation
versus the effects on nascent protein abundances, similar
cross-referencing of the data (383 proteins common to both da-
tasets) revealed no correlation between the relative decreases
in palmitoylation and the relative decreases in nascent protein
abundances (data not shown; see also Figure S2). However, toChemistry &further substantiate the proposal that the effect of HSV infection
is not due simply to an effect on nascent protein synthesis, we
performed further analysis to compare the effect of protein
synthesis shutoff per se with that due to the complex events
associated with HSV infection. If the effect of HSV infection on
palmitoylation was related to an effect of protein synthesis inhi-
bition per se, then we would expect a correlation between the
datasets for HSV-suppressed palmitoylation and those whose
palmitoylation is affected by protein synthesis inhibition. Thus
relative levels of protein palmitoylation were quantified in unin-
fected cells in the absence and presence of cycloheximide
(Chx), a well-established protein synthesis inhibitor. Using a
SILAC protocol, cells in either light or heavy medium were incu-
bated for 2 hr with YnPal. Chx (50 mg/ml) was then added to
heavy cells but not to the light cells, and YnPal labeling continued
in both sets of cultures for an additional 4 hr. Samples were then
extracted, heavy and light proteins were mixed in a 1:1 ratio and
ligated to AzTB, and palmitoylated proteins affinity enriched.
Following MS measurements, quantification data were returned
for 496 proteins. As expected, levels of palmitoylation were
affected by Chx to different degrees for different proteins (Table
S5). Cross-comparison of the datasets representing relative
palmitoylation levels (for 495 proteins quantified in both experi-
mental sets) as a function of HSV infection or Chx treatment re-
vealed no clear correlation between responses to HSV and Chx
(Figure S2; Table S6). Taken together, these data indicate that
mechanisms other than host protein synthesis shutoff are
involved in selective control of palmitoylation levels during HSV
infection.
Identification of Novel Fatty Acylated HSV-Encoded
Proteins
We next directed our attention to identification of putative viral
proteins that were acylated by the host machinery during infec-
tion. The workflow depicted in Figure 3A was designed toBiology 22, 1008–1017, August 20, 2015 ª2015 The Authors 1011
Figure 4. Infection-Induced Changes to
Nascent Protein Abundances
(A) SILAC-based proteomic workflow.
(B) Experimental results from samples prior to
affinity enrichment: Log2 nascent protein abun-
dance ratio HSV/Mock (n = 3) plotted against
significance of the change measured. Red, pro-
teins with myristoylation requirement (N-terminal
Gly); black, all other proteins quantified. Each
data point represents a protein or a protein group
(Cox et al., 2011).measure HSV-induced changes to the host proteome and was
not optimal for an unambiguous identification of fatty acylated
viral proteins. Therefore to discriminate between bona fide fatty
acylated proteins and abundant HSV-encoded proteins which
might non-specifically bind to the capture beads, we modified
our quantitative metabolic tagging workflow (Figure 5A). Thus,
heavy and light cells were infected (n = 3) with HSV and incu-
bated with either the alkynyl fatty acid probes (heavy) or the nat-
ural fatty acids (light). The natural precursor does not contain a
bio-orthogonal tag (alkyne moiety) and does not undergo che-
moselective ligation to AzTB, thus significant heavy/light signal
enrichment would be expected for fatty acylated proteins over
non-specifically binding proteins. Using parallel pairs of probes,
YnPal and Pal (palmitic acid) or YnMyr and Myr (myristic acid),
nine putative palmitoylated and five putative myristoylated HSV
proteins were identified in two or more samples (Figure S3; Table
S7). The selective and highly significant identification of glyco-
proteins among the HSV proteome suggests that the assign-
ments are highly robust. The set includes gE, gI, gG, gK, US2,
US3, UL56, UL51 (TEG7), and UL24, and, consistent with a
lack of myristoylation consensus in these proteins except for
US2, proteins identified with YnMyr may in fact incorporate
this probe through the palmitoylation pathway. Results support-
ing this conclusion were shown from the observed lack of sensi-
tivity of YnMyr incorporation into HSV-encoded proteins to a
specific and potent myristoylation inhibitor (Frearson et al.,
2010; Goncalves et al., 2012; Table S8). In this analysis we quan-
tified changes in the YnMyr incorporation for 9 out of 11 HSV
proteins possessing a myristoylation motif. UL11 (a known
myristoylated and palmitoylated protein) (Loomis et al., 2001;
MacLean et al., 1989) and gN were not detected in our analyses.
A reasonable explanation for this is the very limited number of
tryptic peptides in these small proteins that are compatible
with MS and tandem MS (MS/MS) detection.
To support our analysis, we examined palmitoylation in two
other herpesvirus strains, HSV-1[KOS] and HSV-2[186] as
summarized in Figure 5B and Table S7. Of 12 putatively palmi-
toylated HSV proteins which constitute over 15%of the viral pro-
teome (Apweiler et al., 2004), seven (gE, gI, gK, UL51, UL24,
US2, US3) were common for all three strains and one (UL56)
for at least two strains, whereas one (gH) was shown to be spe-
cific for HSV-2 and one (gG) to be specific for HSV-1.1012 Chemistry & Biology 22, 1008–1017, August 20, 2015 ª2015 The AuthorsIn additional work, we employed acyl-
RAC (resin-assisted capture), an orthog-
onal approach to profile S-fatty acylation
of proteins, to support the identification of
HSV-encoded protein palmitoylation andprovide additional information on the sites of S-acylation in these
proteins (Forrester et al., 2011). In brief, free cysteines on pro-
teins were capped, thioesters selectively hydrolyzed with hy-
droxylamine (this step is performed without hydroxylamine in
the control sample), newly exposed free cysteines captured
with a thiol-reactive resin, and bulk protein removed by on-resin
digestion. Finally, captured peptides were selectively released
from the resin and sequenced by MS/MS, permitting indirect
identification of the cysteine on which S-acylation was originally
installed. Thus cells were infected (n = 3) with HSV-1[17] and pro-
tein lysates subjected to acyl-RAC, revealing eight distinct
S-fatty acylation sites on five of the HSV proteins (Table 1) that
were also identified as palmitoylated by the method described
above.
DISCUSSION
We report a pathway and workflow to enable whole-proteome
insights into protein acylation during infection with a large
complex DNA virus, HSV. Our work highlights the coupling of
dramatic reductions in protein myristoylation to the suppression
of nascent protein synthesis and the identification of several
specific host palmitoylated proteins whose modification is
specifically suppressed during infection. The annotated func-
tions of these latter proteins relate predominantly to membrane
compartmentalization and protein trafficking, likely reflecting
selective modulation of these pathways by altered palmitoyla-
tion during the progression of infection. In this regard it is note-
worthy that protein S-palmitoylation is largely mediated by the
zDHHC family of membrane-associated enzymes, which may
be themselves regulated by palmitoylation. Our dataset in-
cludes relative palmitoylation levels for 11 zDHHC enzymes
of which selective underpalmitoylation in infected cells was
observed for zDHHC20, a zDHHC member that exhibits sub-
strate specificity for a number of integral membrane proteins
(Ohno et al., 2012). Down-regulation of zDHHC20 could
contribute to the observed protein underpalmitoylation of inte-
gral membrane proteins reported above, although clearly other
mechanisms, including suppressed activities of S-palmitoyl
transferases that were not returned in our dataset or enhanced
activities of acyl protein thioesterases, may be involved. Of
the target set with selectively reduced palmitoylation, gene
Figure 5. SILAC-Based Identification of
Fatty Acylated HSV-Encoded Proteins
(A) SILAC-based experimental workflow.
(B) Heatmap for YnPal/Pal (25 mM, 5–19 hpi)
enrichment (n = 3) of proteins derived from HSV-1
[17], HSV-1[KOS], and HSV-2[186]. Black to red
gradation represents the degree (n = 3) of enrich-
ment of proteins labeled with YnPal over Pal, ex-
pressed as a heatmap. Gray bars represent
missing values (applied when quantification was
missing for more than one out of three samples).ontology annotation analysis (Table S9) revealed statistically
significant enrichment in terms (Huang et al., 2009) including
location to plasma membrane (63 proteins) and Golgi apparatus
(26 proteins), and involvement in processes such as vesicle-
mediated transport (19 proteins) and ion transport (17 proteins).
As indicated above, the most commonly enriched protein
domain term was tetraspanin (9 proteins), and the most popu-
lated pathway was SNARE interactions in vesicular transport
(8 proteins).
We further provide robust data expanding the list of HSV-
encoded proteins subject to acylation, and demonstrate that
cysteine S-acylation predominates, with differences in modifica-
tion in HSV-1 versus HSV-2 for at least two modified proteins.
Previous work has demonstrated that numerous viruses encode
palmitoylated proteins that play important roles in the process of
virus assembly and release, and, as discussed in the introduc-
tion, herpesvirus-encoded palmitoylated proteins have been
identified. Here we expand significantly on the number of HSV-
encoded acylated proteins and identify in particular gE, gI, gK,
and the proteins US9, US2, and US3, each of which play multiple
and key roles during infection, including viral entry and release,
cell-to-cell spread, viral immune evasion, and inhibition of
apoptosis. Considering in particular that palmitoylation modifi-
cation is reversible, subject to cycles of palmitoylation/depalmi-
toylation it can be involved in the regulation of diverse aspects of
subcellular localization, conformation, protein-protein interac-
tions, and activity of proteins. Our work now sets the stage to
pursue functional analysis of the role of acylation in these pro-
teins using a combination of approaches including, for example,
the effect of inhibitors on activity and localization and site-
directed mutagenesis of the individual residues subject to
modification.Chemistry & Biology 22, 1008–1017,SIGNIFICANCE
This study represents the first example
of modern chemical proteomics tools,
namely bio-orthogonal probes and
capture reagents, applied systemati-
cally to investigate protein fatty
acylation events on both host- and
virus-encoded proteins during viral
infection. With this technology, we
were able to quantify infection-in-
duced changes to fatty acylation of
hundreds of host proteins (some
of which are involved in immuneresponse and modulation of the progression of infection).
Furthermore, we also demonstrate increased sensitivity of
the technique over previous routes, and identify novel
virus-encoded proteins, indicating that a significant fraction
of viral proteome is subject to fatty acylation. Having estab-
lished a robust workflow for thorough analysis of acylation
during HSV infection, our work sets the stage for further
studies aiming to decipher the importance of fatty acylation
to host and viral protein function and location in cells, and in
the formation of viral particles.
EXPERIMENTAL PROCEDURES
Chemical Tools
Tetradec-13-ynoic acid (YnMyr) (Goncalves et al., 2012), heptadec-16-ynoic
acid (YnPal) (Milne et al., 2010), N-myristoyl transferase inhibitor (DDD85646)
(Frearson et al., 2010; Goncalves et al., 2012), and AzTB (Heal et al., 2012)
were synthesized as described previously. Myristic (Myr) and palmitic (Pal)
acids and all other chemicals were purchased.
Cells and Viruses
RPE-1 (immortalized retinal pigment epithelial) cells were grown in DMEM-F12
medium containing 10% serum, 100 mM L-glutamine, and penicillin-strepto-
mycin, in a humidified 5% CO2 containing atmosphere at 37
C. Cells were
plated at least 24 hr before treatment with chemical probes and/or virus infec-
tion. Virus strains have been previously described and included HSV-1[17],
HSV-1[KOS], and HSV-2[186].
Metabolic Tagging Experiments with In-Gel Fluorescent Detection
Cells were inoculated with serum-free DMEM-F12 media in the presence
(infection) or absence (mock) of HSV at MOI = 5 for 1 hr. The media were
removed and replaced by fresh DMEM-F12 containing 2% newborn calf
serum (NCS) and lipid probes (25 mM YnMyr or YnPal). The cells were washed
with ice-cold PBS (23) and harvested at 19 hpi in SDS lysis buffer. For
time-course experiments, the cells were pulse incubated with the probes atAugust 20, 2015 ª2015 The Authors 1013
Table 1. Palmitoylation Sites on Proteins Identified by Acyl-RAC
Gene Modified Sequence Site Sample z m/z Errora Score D Score Intensity
gG _YVCLPSERG C232 A 2 540.7608 0.2964 105.1 96.866 27,290,000
gG _YVCLPSERG C232 A 2 540.7608 0.7457 53.76 48.216 3,025,400
gG _YVCLPSERG C232 A 2 540.7608 0.4422 53.76 48.216 3,450,800
gG _YVCLPSERG C232 B 2 540.7608 0.0884 117.9 100.38 68,265,000
gG _YVCLPSERG C232 B 2 540.7608 0.2183 74.46 67.185 7,849,900
gG _YVCLPSERG C232 C 2 540.7608 0.5153 108.7 100.16 9,156,000
gI _RPAVAFALCR_ C108 B 3 387.5501 0.2648 61.77 52.059 8,923,800
gI _RPAVAFALCR_ C108 B 3 387.5501 0.1724 69.28 59.495 8,617,300
gI _RPAVAFALCR_ C108 B 3 387.5501 0.2043 58.7 52.386 2,518,600
gI _RPAVAFALCR_ C108 C 3 387.5501 0.5562 60.4 50.743 910,210
gI _RPIYSPQMPTGISCAVNEAAMAR_ C321 B 3 840.7434 0.1068 37.37 34.878 2,856,600
gI _RPIYSPQMPTGISCAVNEAAMAR_ C321 C 3 840.7434 0.5254 37.82 35.717 3,090,200
TEG7 _AAPCVLGQ C240 A 2 408.2076 0.3092 35.36 31.964 11,740,000
TEG7 _AAPCVLGQ C240 B 2 408.2076 0.2111 46.02 42.624 21,662,000
TEG7 _TYHACMVNLER_ C78 A 3 465.2166 0.2680 52.39 43.981 8,275,000
TEG7 _TYHACMVNLER_ C78 B 3 465.2166 0.0848 37.14 30.708 5,543,200
TEG7 _TYHACMVNLER_ C78 B 3 465.2166 0.2983 60.64 36.918 6,623,500
TEG7 _TYHACMVNLER_ C78 B 3 465.2166 0.0930 88.13 74.325 23,976,000
TEG7 _TYHACMVNLER_ C78 B 3 465.2166 0.0122 67.93 50.191 17,289,000
TEG7 _TYHACMVNLER_ C78 B 3 465.2166 0.2979 43.9 35.487 8,906,500
UL24 _IAALFCVPVATK_ C255 A 2 645.3679 0.1287 85.55 72.154 15,173,000
UL24 _IAALFCVPVATK_ C255 B 2 645.3679 0.0379 96.82 83.42 20,055,000
UL24 _IAALFCVPVATK_ C255 C 2 645.3679 0.0554 95.42 82.017 14,522,000
US02 _LPHICYPVTTL C285 A 2 657.3497 0.0473 62.56 53.857 5,930,000
US02 _LPHICYPVTTL C286 B 2 657.3497 0.1274 64.71 59.496 5,752,800
US02 _LPHICYPVTTL C287 C 2 657.3497 0.0611 59.15 53.937 4,252,600
US02 _RPCCACMGMPEVPDEQPTSPGR_ C244b A 3 844.6901 0.4280 51.88 51.761 17,659,000
US02 _RPCCACMGMPEVPDEQPTSPGR_ C244b B 3 844.6901 0.3033 34.65 34.404 8,687,600
US02 _RPCCACMGMPEVPDEQPTSPGR_ C244b C 3 844.6901 0.7995 42.35 42.348 4,100,600
aError given in ppm.
bAlternative sites exist on this peptide (C245 and C247), and cannot be distinguished by Acyl-RAC.1–7 hpi, 7–13 hpi, and 13–19 hpi, and harvested at the end of the respective
pulse.
Metabolic Tagging Experiments with MS Detection and SILAC-
Based Quantification
Cells referred to as heavy were cultured in SILAC R10K8 DMEM-F12 medium
containing 13C6
15N4-Arginine and
13C6
15N2-lysine supplemented with 10%
dialyzed fetal bovine serum (FBS) for at least five passages (at least ten
doublings). Cell dissociation buffer was used to detach cells during splitting.
Cells referred to as intermediate and light were treated analogously, but the
SILAC R6K4 DMEM-F12 medium they were grown in contained 13C6-arginine
and 2H4-lysine or arginine and lysine at their natural isotopic abundances,
respectively.
Differential Levels of Lipidation in Virus- and Mock-Infected Cells
Four populations of heavy cells and four populations of light cells (23 107 cells
each) were infected with HSV-1[17] at MOI = 5 or mock infected in serum-free
SILAC DMEM-F12 media for 1 hr. Media were removed and replaced by fresh
SILAC DMEM-F12 supplemented with 2% dialyzed FBS and lipid probes
(25 mM YnMyr or YnPal). At 19 hpi, the cells were washed with ice-cold PBS
(23) and harvested in SDS lysis buffer (500 ml). Samples were probe sonicated
on ice and spun at 5,000 3 g for 20 min to remove insoluble nuclear material.
Protein concentration was determined and the samples were stored at80C
awaiting further processing. Prior to the next processing step, heavy virus-1014 Chemistry & Biology 22, 1008–1017, August 20, 2015 ª2015 Thinfected lysates were mixed with light mock-infected lysates and light virus-
infected lysates were mixed with heavy mock-infected lysates, in 1:1 ratio
(based on the protein concentration determined). Sample mixtures were
either digested in-solution or on-bead (following chemical ligation and affinity
enrichment).
Determination of Lipidated HSV-Encoded Proteins
For each virus applied, three populations of heavy cells and three populations
of light cells (23 107 cells each) were infected at MOI = 5 in serum-free SILAC
DMEM-F12 media for 1 hr. Media were removed and replaced by fresh SILAC
DMEM-F12 supplemented with 2% dialyzed FBS. At 6 hpi, heavy media were
supplemented with lipid probes (40 mM YnMyr or YnPal) and light media were
supplemented with natural lipids (40 mM Myr or Pal). At 19 hpi, the cells
were washed with ice-cold PBS (23) and harvested in SDS lysis buffer (500 ml).
Differential Levels of Lipidation in Cells Cultured in the Presence or
Absence of Cycloheximide
In experiments involving protein synthesis inhibitor (Chx), two populations of
light cells and two populations of heavy cells (n = 2) were incubated with YnPal
(25 mM) for 2 hr prior to the addition of Chx (50 mg/ml) to the heavy cells, and
incubation continued for another 4 hr. Cells were washed with ice-cold PBS
(23) and harvested in SDS lysis buffer (500 ml). Samples were probe sonicated
on ice and spun at 5,000 3 g for 20 min to remove insoluble nuclear material.
Protein concentration was determined and the samples were stored at80C
to await further processing. Prior to the next processing step (chemicale Authors
ligation), heavy lysates were mixed with light lysates in 1:1 ratio (based on the
protein concentration determined).
In experiments involving N-myristoyltransferase inhibitor DDD85646, light
cells were supplemented either with DDD85646 (5 mM) or the vehicle (DMSO)
at 1 hpi together with YnMyr (25 mM). At 19 hpi, the cells were washed with
ice-cold PBS (23) and harvested in SDS lysis buffer (500 ml). ‘‘Spike-in stan-
dards’’ were generated by incubation of heavy cells with YnMyr (25 mM) from
1 to 19 hpi. Samples were probe sonicated on ice and spun at 5,000 3 g for
20 min to remove insoluble nuclear material. Protein concentration was deter-
mined and the samples were stored at80C to await further processing. Prior
to the next processing step (chemical ligation), heavy lysates were mixed with
light lysates in 1:3 ratio (based on the protein concentration determined).
Differential Protein Synthesis Rates in Virus- and Mock-Infected
Cells
Three populations of light cells (2 3 107 cells each) were infected with HSV-1
[17] at MOI = 5, and three populations of light cells (2 3 107 cells each) were
mock infected in serum-free heavy SILAC R10K8 DMEM-F12 supplemented
with YnMyr (25 mM) for 6 hr. Media were removed and replaced by fresh heavy
SILAC 10K8 DMEM-F12 supplemented with 2% dialyzed FBS and YnMyr
(25 mM). At 19 hpi, the cells were washed with ice-cold PBS (23) and har-
vested in SDS lysis buffer. Samples were probe sonicated on ice and spun
at 5,0003 g for 20min to remove insoluble nuclearmaterial. An additional pop-
ulation of cells cultured in intermediate SILAC R6K4 DMEM-F12 (uninfected)
and metabolically tagged with YnMyr (25 mM, 8 hr) was harvested in SDS lysis
buffer (and treated further as above) and applied as a spike-in standard (Geiger
et al., 2011). Protein concentration was determined and the samples were
stored at 80C to await further processing. Before further processing,
light-heavy and intermediate lysates were mixed at 4:1 ratio (based on the pro-
tein concentration determined). Sample mixtures were either digested in-solu-
tion or on-bead (following chemical ligation and affinity enrichment).
Chemical Ligation with CuAAC
Lysates were thawed on ice. 200 mg (in-gel fluorescence) or 800 mg (MS) of pro-
teins were taken and diluted to 2 mg/ml using SDS lysis buffer and 13 PBS
(final SDS concentration in samples was adjusted to 1%). A click mixture
was prepared by adding reagents together in the following order and by vortex
mixing between the addition of each reagent: AzTB (1 or 4 ml, stock solution
10 mM in water, final concentration 0.1 mM), CuSO4 (2 or 8 ml, stock solution
50 mM in water, final concentration 1 mM), tris(2-carboxyethyl)phosphine
(TCEP) (2 or 8 ml, stock solution 50 mM in water, final concentration 1 mM),
tris(benzyltriazoylmethyl)amine (1 or 4 ml, stock solution 10 mM in DMSO,
final concentration 0.1 mM). Following the addition of the click mixture (6 or
24 ml/sample) the samples were vortex mixed for 1 hr at room temperature
(RT), and the reaction was stopped by addition of EDTA (2 or 8 ml, stock solu-
tion 500mM inwater, final concentration 10mM). Subsequently, proteins were
precipitated (chloroform/methanol/sample, 0.25:1:1 v/v/v), precipitated pro-
tein pellets isolated by centrifugation (17,000 3 g, 10 min), washed twice
with methanol (1,000 ml), and air dried. The pellets were then reconstituted in
SDS lysis buffer, diluted to 0.4%SDSwith PBS, and final protein concentration
of 1 mg/ml. Insoluble material was removed by centrifugation.
Protein Enrichment on Avidin Beads
For proteomics experiments (400 mg of proteins), agarose beads (40 ml of pre-
washed) were added to proteins in 0.4% SDS in PBS (1 mg/ml). The mixtures
were gently vortex mixed for 90 min at RT. The supernatant was removed and
the beads washed with 1% SDS in PBS (3 3 1 ml), and then with 100 mM
ammonium bicarbonate (AMBIC) (3 3 1 ml). The beads were incubated with
5 mM TCEP in 100 mM AMBIC (100 ml) for 20 min at 55C, washed with
50 mM AMBIC, and incubated with 5 mM iodoacetamide in 100 mM AMBIC
(100 ml) for 20 min at RT in the dark. The beads were subsequently washed
with 50 mM AMBIC (4 3 1 ml). On-bead tryptic digest was performed in the
next step (see below).
For small-scale experiments (100 mg of proteins), magnetic beads (15 ml of
pre-washed) were added to proteins in 0.4% SDS in PBS (1 mg/ml). The mix-
tures were gently vortexmixed for 90min at RT. The supernatant was removed
and the beads washed with 1% SDS in PBS (3 3 500 ml). Proteins were
released from the beads in the next step (see below).Chemistry &Determination of Palmitoylation Sites for HSV-Encoded Proteins
Three populations of cells (4 3 107 cells each) cultured in DMEM-F12 (non-
SILAC) were infected with HSV-1[17] at MOI = 5 in serum-free DMEM-F12 for
1 hr. The media were removed and replaced by fresh DMEM-F12 supple-
mented with 2% NCS. At 19 hpi, the cells were washed with ice-cold PBS
(23) and harvested in 2% SDS in Tris buffer (100 mM, pH 7.5). Samples were
probe sonicated on ice and spun at 5,000 3 g for 20 min to remove insoluble
nuclear material. Protein concentration was determined. The lysates (4 mg of
proteins each) were diluted with Tris buffer (100 mM, pH 7.5) to the final SDS
concentration of 1%andprotein concentration of 2mg/ml. Toblock non-palmi-
toylated cysteines, samples were treated with TCEP (final concentration 5 mM)
and N-ethylmaleimide (final concentration 10 mM) for 30 min at 40C. Proteins
were precipitated (chloroform/methanol/sample 0.25:1:1 v/v/v), protein pellets
isolated by centrifugation (17,000 3 g, 10 min), washed with methanol
(5 3 1 ml), and air dried. Proteins were reconstituted in 2% SDS in Tris buffer
(100mM, pH 7.5), dilutedwith Tris buffer (100mM, pH 7.5) to the final SDS con-
centration of 1.5%andprotein concentration of 3mg/ml, and spun (17,0003 g,
10 min) to remove traces of insoluble material. Each sample was then divided
into two parts, to produce two groups of three samples. One groupwas treated
with freshly prepared hydroxylamine (500 ml of 1 M, stock solution prepared in
100mMTris buffer andpHadjusted to 7.5, final concentration 0.25M),whereas
the second (control) group was treated with NaCl (500 ml of 1 M, stock solution
prepared in 100mM Tris buffer and pH confirmed to be 7.5, final concentration
0.25 M) for 2 hr at RT, both in the presence of Thiopropyl Sepharose 6B resin
(20mgper sample, pre-swollen according to themanufacturer’s recommenda-
tion). Hydroxylamine solutionwas produced by neutralization of hydroxylamine
hydrochloride with NaOH, hence the addition of NaCl to the control samples.
The resin was spun (7,000 3 g, 4 min), supernatant discarded, and the resin
washed with 2% SDS in Tris buffer (3 3 1 ml) and Tris buffer (3 3 1 ml). On-
bead digestion was performed in the next step (see below).
SDS-PAGE and In-Gel Fluorescence
Total cell lysates were boiled in 13 SLB (NuPAGE LDS sample buffer; Invitro-
gen) for 5 min, whereas enriched proteins bound to magnetic beads were
boiled in 13 SLB for 10 min. Supernatants separated from beads or cell sam-
ples loaded on Tris-acetate SDS-PAGE gels (12%). Following electrophoresis
(90 min, 150 V), gels were soaked in a fixing solution (40%MeOH, 10% acetic
acid, 50% water) and washed with water (33), in-gel fluorescence was re-
corded, and the protein loading was analyzed by Coomassie staining.
Tryptic Digest and MS Sample Preparation
Proteins bound to NeutrAvidin-agarose beads (40 ml) were incubated with
sequencing-grade trypsin (0.5 mg) in 50 mM AMBIC (100 ml) for 16–20 hr in a
thermo-shaker set to 37C. The reaction was terminated with trifluoroacetic
acid (0.5 ml) and the beads spun (7,0003 g, 4 min). Supernatant was removed
and kept aside. The beads were washed with 0.5% trifluoroacetic acid (50 ml),
spun again (7,000 3 g, 4 min) and the second supernatant combined with the
one that was set aside. Tryptic peptides in the supernatant were desalted by
the Stage-Tip method as described elsewhere (Broncel et al., 2015). Elution
from the sorbent (SDB-XC poly(styrenedivinylbenzene) copolymer, from 3 M)
with 70% acetonitrile in water was followed by Speed-Vac-assisted solvent
removal. Peptides were reconstituted in water containing 0.5% trifluoroacetic
acid and 2% acetonitrile and transfer of samples into liquid chromatography-
MS sample vials.
Proteins bound to Thiopropyl Sepharose 6B resin were suspended in
100 mM Tris buffer (pH 8) (100 ml), sequencing-grade trypsin (0.5 mg) added,
and the mixtures incubated for 16 hr in a thermo-shaker set to 37C. The resin
was spun (7,0003 g, 4 min), the supernatant discarded, resin washed with 2%
SDS in Tris buffer (3 3 1 ml), Tris buffer (3 3 1 ml), 80% aqueous acetonitrile
(3 3 1 ml), 50% aqueous methanol (3 3 1 ml), and 50 mM AMBIC (3 3 1 ml).
Thiol-containing peptides were eluted from the resin by the incubation with
DTT (final concentration 50 mM) for 40 min at 40C. The resin was spun
(7,0003 g, 4 min), supernatant withdrawn, desalted by the Stage-Tip method,
and processed further as described above.
In-solution digestion was performed on non-enriched samples (total cell
lysates). To remove the detergent, proteins (50 mg) were precipitated from lysis
buffer solutions by addition of methanol (400 ml), chloroform (100 ml), and water
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washed (33) with methanol (1,000 ml), and air dried. The pellets were then
reconstituted in 50 mM AMBIC (100 ml), TCEP (5 ml, 100 mM) added, and the
mixtures incubated for 20 min at 55C. Subsequently, iodoacetamide (5 ml,
100 mM) was added and the mixtures left for 20 min at RT in the dark.
Sequencing-grade trypsin (0.5 mg) was added and the mixtures were incu-
bated for 16–20 hr in a thermo-shaker set to 37C. The reactionwas terminated
with trifluoroacetic acid (0.5 ml), and the peptide mixtures were desalted by the
Stage-Tip method and processed further as above.
Mass Spectrometry
The analysis was performed using an Acclaim PepMap RSLC column of
50 cm 3 75 mm inner diameter (Thermo Fisher Scientific) using a 2-hr acetoni-
trile gradient in 0.1% aqueous formic acid at a flow rate of 250 nl/min. Easy
nLC-1000 was coupled to a Q Exactive mass spectrometer via an easy-spray
source (all Thermo Fisher Scientific). The Q Exactive was operated in data-
dependent mode with survey scans acquired at a resolution of 75,000 at m/z
200 (transient time 256 ms). Up to ten of the most abundant isotope patterns
with charge +2 or higher from the survey scan were selected with an isolation
window of 3.0 m/z and fragmented by higher-energy collisional dissociation
with normalized collision energies of 25. The maximum ion injection times
for the survey scan and the MS/MS scans (acquired with a resolution of
17,500 at m/z 200) were 20 and 120 ms, respectively. The ion target value
for MS was set to 106 and for MS/MS to 105, and the intensity threshold was
set to 8.3 3 102.
Proteomics Data Analysis
The data were processed with MaxQuant (Cox and Mann, 2008) (versions 1.3
and 1.5) and the peptides were identified from the MS/MS spectra searched
against reference human and either herpesvirus type 1 (strain 17) or herpes-
virus type 2 (strain HG52), depending on the virus type used in the experiment,
proteomes (Apweiler et al., 2004) using the Andromeda (Cox et al., 2011)
search engine. Cysteine carbamidomethylation was selected as a fixed modi-
fication (except for acyl-RAC samples) and methionine oxidation as a variable
modification. For in silico digests of reference proteomes the following peptide
bond cleavages were allowed: arginine or lysine followed by any amino acid
(a general setting referred to as trypsin/P). Heavy/intermediate/light isotopic
forms of arginine and lysine were used where appropriate. Complete datasets
that corresponded to a particular experiment were always analyzed together
with match between runs, with the re-quantify function enabled in the
software. Up to two missed cleavages were allowed. The false discovery
rate was set to 0.01 for peptides, proteins, and sites. Other parameters were
used as pre-set in the software. ‘‘Unique and razor peptides’’ mode was
selected to allow identification and quantification of proteins in groups (razor
peptides are uniquely assigned to protein groups and not to individual pro-
teins). Data were further processed using Perseus software (version 1.5).
In the case of SILAC experiments, contaminants, reverse, and identified by
site hits were removed, and SILAC ratio values were logarithmized (Log2). The
replicates were grouped together, and at least two valid values across three
(viral protein lipidation or host nascent protein abundance) or four (host protein
lipidation) replicates were required. For each double SILAC experiment, a
one-sample test (Benjamini-Hochberg false discovery rate = 0.05) imple-
mented in the software was performed to assess statistical significance of dif-
ferences between measured SILAC ratios and the median SILAC distribution
for all quantified proteins (set to Log2 = 0). For the pulse-SILAC experiment
(host nascent protein abundance), a two-sample test (permutation-based
false discovery rate = 0.05) implemented in the software was performed to
assess statistical significance of differences between SILAC ratios measured
for HSV-infected and mock-infected samples. Palmitoylation data were used
without filtering, whereas myristoylation data were filtered in Perseus through
a modified fasta file comprising only N-terminal MG proteins (the sequence
requirement for co-translational myristoylation).
SILAC samples prepared from YnPal labeling experiments in the presence
or absence of Chx (two biological duplicates) were measured twice (technical
duplicates), and the duplicate data pulled in during MaxQuant analysis to
enhance identification and provide more robust quantification.
In the case of acyl-RAC, sequential filtering was performed in Perseus to
minimize false discovery. Peptides belonging to the following categories
were removed: contaminant and reverse; also identified in sodium chloride-1016 Chemistry & Biology 22, 1008–1017, August 20, 2015 ª2015 Thtreated (hydroxylamine untreated) control samples; corresponding to proteins
neither quantified nor significantly enriched in YnPal/Pal experiments for HSV-
1[17]; possessing delta score <30; found in less than two out of three samples.
The heatmap and two-dimensional charts (Figure 5B; FiguresS2 andS3)were
prepared in Perseus. Tables S1, S2, S3, S4, S5, S6, S7, and S8 were created in
Excel from data exported as .txt files from Perseus. Functional annotation anal-
ysis (Table S9) was performed using David Bioinformatics Resources. Term
enrichment analysis was performed with human proteome applied as a back-
ground and the following threshold: minimal count = 3; ease = 0.001.
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